Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
23 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hotspot-therapeutics-presents-preclinical-data-from-malt1-cbm-signalosome-glue-program-at-36th-eortc-nci-aacr-symposium-302284027.html
19 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hotspot-therapeutics-appoints-alison-oneill-md-as-chief-medical-officer-302252482.html
12 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hotspot-therapeutics-presents-first-in-human-phase-1-clinical-data-on-its-novel-cbl-b-inhibitor-hst-1011-at-esmo-congress-2024-302246957.html
17 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hotspot-therapeutics-to-present-initial-first-in-human-phase-1-clinical-data-on-its-novel-cbl-b-inhibitor-hst-1011-at-esmo-congress-2024-302198838.html
20 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hotspot-therapeutics-presents-preclinical-data-for-potential-first-in-class-malt1-scaffolding-inhibitor-at-the-4th-aacr-international-meeting-advances-in-malignant-lymphoma-302177499.html
11 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hotspot-therapeutics-presents-preclinical-data-for-potential-first-in-class-malt1-scaffolding-inhibitor-at-65th-ash-annual-meeting-302009437.html
ABOUT THIS PAGE